Cell and gene therapies are advancing at a rapid rate, but huge costs and time-consuming manual manufacturing processes are keeping therapies out of reach for most...
By Alison MacDonald, Global Lead for EPR Implementation
By Pamela James, Ph.D., Vice President, Product, Vector Laboratories
By Dr Pamela Walker, Healthcare expert, Advisor and Investor
By Radar Healthcare co-founder and CEO, Paul Johnson
By Sofie McPherson, Patent Director, HGF
Your path to more affordable & accessible online behavioural health care